Literature DB >> 10567978

Mortality in rheumatoid arthritis.

C Guedes1, D Dumont-Fischer, S Leichter-Nakache, M C Boissier.   

Abstract

Rheumatoid arthritis reduces not only quality but also length of life. In the 14 main studies conducted since 1980, in a total of 13,424 patients, the mean standardized mortality ratio was 1.82 (range, 0.87-3) as compared to the population at large. Life expectancy was shortened by 5 to 10 years in most studies. The diversity of the methods used explains the discrepancies among results. Excess mortality may occur in only some subsets of patients. Both rheumatoid complications and an increase in nonspecific causes of death (e.g., infections) contribute to the excess mortality. Factors predictive of premature death are the same as those predictive of functional impairment. Many unknowns remain about the condition of rheumatoid arthritis patients at the end of their life.

Entities:  

Mesh:

Year:  1999        PMID: 10567978

Source DB:  PubMed          Journal:  Rev Rhum Engl Ed        ISSN: 1169-8446


  4 in total

1.  An inverse association between self-reported arthritis and mortality in the elderly: findings from the national long-term care survey.

Authors:  Alexander M Kulminski; Irina V Kulminskaya; Svetlana V Ukraintseva; Kenneth Land; Anatoli I Yashin
Journal:  Rejuvenation Res       Date:  2008-02       Impact factor: 4.663

Review 2.  Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.

Authors:  Christine R Culy; Gillian M Keating
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment.

Authors:  Maria Rehnberg; Mikael Brisslert; Sylvie Amu; Kiandoht Zendjanchi; Gunilla Håwi; Maria I Bokarewa
Journal:  Arthritis Res Ther       Date:  2010-06-08       Impact factor: 5.156

Review 4.  Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?

Authors:  Klaus P Machold; Valerie P K Nell; Tanja A Stamm; Josef S Smolen
Journal:  Arthritis Res Ther       Date:  2006-05-15       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.